Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sex hormone injections for hospitalized COVID-19 patients with acute organ failure
IRCT20150716023235N15Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of testosterone, medroxyprogesterone acetate and progesterone in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Severity of symptoms. Started May 2020; status: completed.
02
Drugs
testosteronemedroxyprogesterone acetateprogesterone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20150716023235N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150716023235N15.